[Efficacy and tolerability of thymopoietin in patients at risk of infection]
- PMID: 3321257
[Efficacy and tolerability of thymopoietin in patients at risk of infection]
Similar articles
-
[Possible selective effects of thymopentin on polymorphonuclear activity in patients undergoing dialysis].Recenti Prog Med. 1989 Sep;80(9):499. Recenti Prog Med. 1989. PMID: 2687987 Italian. No abstract available.
-
[Thymic hormone treatment of acute and chronic respiratory infections in the elderly].Recenti Prog Med. 1989 Jul-Aug;80(7-8):438-41. Recenti Prog Med. 1989. PMID: 2682857 Clinical Trial. Italian.
-
[Immunomodulating therapy in chronic polyarthritis with thymopentin. A multicenter placebo-controlled study of 119 patients].Dtsch Med Wochenschr. 1988 Feb 5;113(5):172-6. doi: 10.1055/s-2008-1067614. Dtsch Med Wochenschr. 1988. PMID: 3276492 Clinical Trial. German.
-
Thymopentin in dermatology.Curr Probl Dermatol. 1989;18:283-9. doi: 10.1159/000416866. Curr Probl Dermatol. 1989. PMID: 2663371 Review. No abstract available.
-
Immunostimulation by TP-5 in immunocompromised patients and animals--current status of investigation.Comp Immunol Microbiol Infect Dis. 1986;9(2-3):225-32. doi: 10.1016/0147-9571(86)90015-9. Comp Immunol Microbiol Infect Dis. 1986. PMID: 3539496 Review.
Cited by
-
Thymic peptides for treatment of cancer patients.Cochrane Database Syst Rev. 2011 Feb 16;2011(2):CD003993. doi: 10.1002/14651858.CD003993.pub3. Cochrane Database Syst Rev. 2011. PMID: 21328265 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical